Article

October 26, 2011

Dr. Darren Saks Explains Why the Significant Cost of an Electronic Health Record System Is Worthwhile

Dr. Darren Saks, of Tenafly Pediatrics in New Jersey, addresses why he thinks it's worthwhile for medical practices to invest in an EHR system rather than strictly an ePrescribing device.

Dr. Saks also discusses how Tenafly Pediatrics, which consists of 6 offices and 20 physicians, has benefitted from using EHR technology both from a patient efficiency and satisfaction standpoint, with the extra bonus of such improvements adding to the practices' prestige.

Related Videos

Hasenin Al-khersan, MD

Jade E. Jones, MD

Dr Maria DeYoreo

Screenshot of an interview with Rohan Garje, MD

Susan Escudier, MD, FACP

Sabarish Ayyappan, MD

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health

Katie Abouzahr, MD

Related Content

Ioana Bonta, MD

February 20th 2025

NSCLC Advancements Offer Hope, but Disparities Persist

Kyle Munz Ioana Bonta, MD

Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Antoine Keller, MD

February 18th 2025

HeartSense's Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities

Kyle Munz Antoine Keller, MD, FACC, FACS

Antoine Keller, MD, founded HeartSense with the purpose of uncovering and addressing the cardiovascular needs of rural, often underserved communities.

February 4th 2025

Politics vs Science: The Future of US Public Health

Maggie L. Shaw Perry N. Halkitis, PhD, MS, MPH

On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.

Joshua Kaufman, MD

February 11th 2025

Advancing Integrated Care for Comorbid Schizophrenia and Substance Use Disorder

Giuliana Grossi Joshua Kaufman, MD

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid schizophrenia and substance use disorder.

Christian Ruff, MD

February 11th 2025

Abelacimab Shows Potential to Shift the Standard of Care in AFib

Kyle Munz Christian Ruff, MD Dan Bloomfield, MD

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

Related Content

Ioana Bonta, MD

February 20th 2025

NSCLC Advancements Offer Hope, but Disparities Persist

Kyle Munz Ioana Bonta, MD

Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Antoine Keller, MD

February 18th 2025

HeartSense's Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities

Kyle Munz Antoine Keller, MD, FACC, FACS

Antoine Keller, MD, founded HeartSense with the purpose of uncovering and addressing the cardiovascular needs of rural, often underserved communities.

February 4th 2025

Politics vs Science: The Future of US Public Health

Maggie L. Shaw Perry N. Halkitis, PhD, MS, MPH

On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.

Joshua Kaufman, MD

February 11th 2025

Advancing Integrated Care for Comorbid Schizophrenia and Substance Use Disorder

Giuliana Grossi Joshua Kaufman, MD

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid schizophrenia and substance use disorder.

Christian Ruff, MD

February 11th 2025

Abelacimab Shows Potential to Shift the Standard of Care in AFib

Kyle Munz Christian Ruff, MD Dan Bloomfield, MD

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions